McKesson Corporation $MCK Shares Sold by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. lowered its position in McKesson Corporation (NYSE:MCK) by 32.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,330 shares of the company’s stock after selling 8,008 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in McKesson were worth $13,943,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. BlackRock Inc. acquired a new position in shares of McKesson during the 2nd quarter worth $8,156,743,000. Bank of America Corp DE purchased a new stake in shares of McKesson in the 2nd quarter worth about $998,896,000. Legal & General Group Plc acquired a new stake in McKesson in the 2nd quarter valued at about $656,566,000. The Manufacturers Life Insurance Company acquired a new stake in McKesson in the 2nd quarter valued at about $651,462,000. Finally, Bank of New York Mellon Corp acquired a new stake in McKesson in the 2nd quarter valued at about $599,060,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on MCK shares. Royal Bank Of Canada restated a “sector perform” rating and set a $845.00 target price on shares of McKesson in a report on Monday, September 14th. Citigroup lifted their target price on shares of McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Friday, July 24th. UBS Group upped their price target on shares of McKesson from $1,080.00 to $1,200.00 and gave the company a “buy” rating in a report on Friday, October 16th. Weiss Ratings raised shares of McKesson from a “buy (b-)” rating to a “buy (b)” rating in a report on Friday, September 4th. Finally, Argus increased their price target on shares of McKesson from $850.00 to $970.00 and gave the company a “buy” rating in a research report on Thursday, September 3rd. Fifteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $997.12.

Insider Buying and Selling

In related news, Director Bradley Lerman sold 301 shares of McKesson stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $892.33, for a total transaction of $268,591.33. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Francisco Fraga sold 800 shares of the business’s stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $995.80, for a total transaction of $796,640.00. Following the completion of the transaction, the executive vice president directly owned 5,423 shares of the company’s stock, valued at $5,400,223.40. The trade was a 12.86% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 1,212 shares of company stock worth $1,164,182. 0.06% of the stock is owned by corporate insiders.

McKesson Stock Performance

McKesson stock opened at $1,014.79 on Thursday. The stock has a fifty day moving average of $905.65 and a two-hundred day moving average of $840.38. The company has a market capitalization of $118.31 billion, a price-to-earnings ratio of 27.16, a PEG ratio of 2.05 and a beta of 0.30. McKesson Corporation has a fifty-two week low of $723.68 and a fifty-two week high of $1,030.27.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share for the quarter, topping analysts’ consensus estimates of $9.56 by $0.37. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%. The company had revenue of $105.38 billion during the quarter, compared to analysts’ expectations of $103.88 billion. During the same period in the previous year, the firm posted $8.26 earnings per share. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, analysts forecast that McKesson Corporation will post 44.71 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be paid a dividend of $0.94 per share. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is presently 10.06%.

Key Stories Impacting McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Analyst price-target increases supported the long-term outlook. UBS raised its target to $1,200, while Mizuho lifted its target to $1,020 from $905, although Mizuho maintained a neutral rating. The analyst actions followed McKesson’s recent strength and helped the stock reach a new one-year high. UBS raises target for McKesson
• Positive Sentiment: McKesson declared its regular quarterly dividend. The company will pay $0.94 per share on January 4, 2027, to shareholders of record on December 1. The dividend provides continuity for income-focused investors, though the annualized yield is modest at approximately 0.4%. McKesson declares quarterly dividend
• Neutral Sentiment: Investor attention remains elevated. McKesson was among the more-trending stocks on Zacks, but the article primarily reviews existing fundamentals rather than introducing a new catalyst. Its latest reported quarter showed earnings and revenue above estimates, with revenue up 7.7% year over year and fiscal 2027 EPS guidance of $44.20–$45.00. Is Trending Stock McKesson a Buy Now?
• Negative Sentiment: An executive sale may have added modest selling pressure. EVP Francisco Fraga sold 800 shares worth approximately $796,640. However, the transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, reducing its significance as a discretionary bearish signal. McKesson executive stock sale

About McKesson

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.